Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

3(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Other(1)

Detailed Status

Completed1

Not yet recruiting1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 13 (100.0%)

Trials by Status

completed133%

not_yet_recruiting133%

unknown133%

Recent Activity

0 active trials

Showing 3 of 3

not_yet_recruitingphase_1

YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer

NCT06662669

unknownphase_1

A Study of HY-0102 in Patients With Advanced Solid Tumors

NCT06094777

completedphase_1

HY-0102 Monotherapy in Patients With Locally Advanced/Metastatic Solid Tumours

NCT04914351

Clinical Trials (3)

Showing 3 of 3 trials

NCT06662669Phase 1

YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer

Not Yet Recruiting

NCT06094777Phase 1

A Study of HY-0102 in Patients With Advanced Solid Tumors

Unknown

NCT04914351Phase 1

HY-0102 Monotherapy in Patients With Locally Advanced/Metastatic Solid Tumours

Completed

All 3 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 3